Veteran Affairs Tests

George Johnston filed this request with the U.S. Department of Veterans Affairs of the United States of America.
Tracking #


Due May 27, 2020
Est. Completion None
Awaiting Response


From: George Johnston

To Whom It May Concern:

Pursuant to the Freedom of Information Act, I hereby request the following records:

All documents and communications pertaining to the 368 male coronavirus patients at VA hospitals nationwide who had died or been discharged as of April 11. 97 of these patients were given hydroxychloroquine. any mention of the word hydroxychloroquine in email communications as well.

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.


George Johnston

From: U.S. Department of Veterans Affairs

Mr. Johnston,

Please see attached acknowledgment letter regarding your FOIA request.

Thank you,

Jay Riahi, MAIS-IC/TS
Quality, Performance, and Risk (QPR) I Office of Information and Technology (OI&T)
O: (202) 461-7762 I C: (202) 322-3652
[LDP logo Super_FINAL (002)]
[cid:image003.png@01D61EE8.933C5920]QPR's Mission Statement:
"To lead a culture of quality and accountability to drive an exceptional Veteran and customer experience"

This message and attachments may contain information that is confidential and/or protected by law. These messages are For Official Use Only and may be exempt from disclosure pursuant to 5 U.S.C. § 552. Do not share with unintended parties. If received in error, please advise sender immediately and destroy. Any unauthorized dissemination or copying of the material in this message, and any attachments to the message, is strictly prohibited.

From: U.S. Department of Veterans Affairs

George Johnston, Attached to this email message is my request for clarification on your 04/27/2020 Freedom of Information Act (FOIA) request, FOIA tracking number 20-06334-F. I am providing you with thirty (30) calendar days to respond to my request for clarification.  If I have not received a response from you by May 31, 2020, I will conclude that you are no longer interested in pursuing this request and will administratively close the case file.  Please refer to the attached letter for details pertaining to my request for clarification. I would kindly appreciate your confirmation of receipt of this email.  A hard copy of the attached letter will not follow in postal mail unless specifically requested by you. If you should have any questions, please feel free to contact me at (785) 230-8430 or via email at ( Sincerely, Stacy Ekis VHA FOIA Officer

From: George Johnston

A copy of the test can be found here.

The tests were authorized by the FDA and performed in all United States Veterans Health Administration medical centers.

From: U.S. Department of Veterans Affairs

Mr. Johnston,

Thank you for identifying the study you were referencing. In order to process your request, clarification is still needed however. As per my letter to you on May 1, 2020; please provide clarification on what records related to this study you are seeking so we may identify and locate the records (i.e. a copy of the report etc.).

I also noted, you are seeking: “any mention of the word hydroxychloroquine in email communications as well.” Per my May 1, 2020 letter; please clarify the extent of emails/communication you are seeking.

If you’d like to discuss further you are welcome to contact me by phone as well.

Thank you,

Stacy Ekis
VHA FOIA Officer
Office of Health Informatics (10A7B)
Veterans Health Administration
Tel. 785-230-8430
Fax. 202-273-9387

From: George Johnston

A copy of the report would be great.

Any emails or communications sent from the respective facilities that mention hydroxychloroquine.

All the best,